Health News

BASEL, Switzerland--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TYO 6523), today announced a strategic partnership with venture-backed health technology startup Sava Technologies to support the introduction and future commercialization of its innovative wearable microsensor. The partnership comprises an exclusive commercialization and distribution agreement, initially in Europe, and a concurrent financing agreement. Under t...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab and hyaluronidase-tqjs) in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of stage III deficient DNA mismatch repair (dMMR) colon cancer, a type of tumor characterized by high mutation rates. This approval marks...

DALLAS--(BUSINESS WIRE)--This October, Dickey’s Barbecue Pit is giving fans more reasons to FALL in love with its barbecue by offering a full lineup of limited-time deals, seasonal specials and feel-good offers available throughout the month. From celebrating 85 years of Legit. Texas. Barbecue.™ to honoring first responders and serving up spooky savings, there’s something for every kind of barbecue fan to bookmark. October 1 – 31, 85th Anniversary Celebration Dickey’s Barbecue Pit is celebratin...

DALLAS--(BUSINESS WIRE)--Concentra® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON) will release the financial results for its third quarter ended September 30, 2026, on Thursday, November 5, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, November 6, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra’s website at https://ir.concent...

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the fourth quarter of 2026. The dividend will be paid on Tuesday, December 1, 2026, to all holders of record of the Company’s common stock as of the close of business on Friday, October 30, 2026. About Zoetis Zoetis is the world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a leg...

ST. LOUIS--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE:RGA) plans to release third quarter earnings on Thursday, November 5, at approximately 4:15 p.m. Eastern Time. The release will be issued via newswire and will also be available through RGA’s website, www.rgare.com.RGA will host a conference call to discuss the third quarter results beginning at 10 a.m. Eastern Time on Friday, November 6. Interested parties may access the call by dialing 1-844-481-2753 (412-317-0669 int...

RICHMOND, Va.--(BUSINESS WIRE)--Genworth Financial, Inc. (NYSE: GNW) today announced it will issue its earnings release containing third quarter results after the market closes on November 4, 2026. A conference call will be held on November 5, 2026, at 10:00 a.m. (ET) to discuss the quarter’s results. Genworth’s earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that Guardant360® CDx has received CE-marking under Europe’s in Vitro Diagnostic Medical Devices Regulation as a companion diagnostic (CDx) to identify patients with estrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer who may benefit from treatment with ETCAMAH™ (camizestrant), AstraZeneca’s next-generation oral selective estrogen...

BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to support the National Science Foundation’s X-Labs program. Ginkgo’s support was announced today by Michael Kratsios, Director of the White House Office of Science and Technology Policy (OSTP), at the Science: A New Golden Age Summit in Washington, D.C. NSF X-Labs is a $1.5 billion, decade-long initiative to fund independent teams of researchers, engin...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting...